{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:22:02Z","timestamp":1793830922369,"version":"4.6.1"},"reference-count":119,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jaad.2017.09.078","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T02:15:35Z","timestamp":1510107335000},"page":"S1-S23.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":301,"special_numbering":"S1","title":["Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne"],"prefix":"10.1016","volume":"78","author":[{"given":"Diane M.","family":"Thiboutot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Dr\u00e9no","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Abanmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Alexis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Araviiskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Barona Cabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Bettoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flordeliz","family":"Casintahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adilson","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam","family":"El Ouazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee-Leok","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald P.M.","family":"Gollnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukazu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Herane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Honeyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sewon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos","family":"Kemeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Kubba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Leyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"L\u00f3pez-Estebaranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nopadon","family":"Noppakun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Ochsendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Oprica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Piquero-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Ann","family":"See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Hun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente Torres","family":"Lozada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Troielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leihong Flora","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.09.078_bib1","series-title":"Textbook of Clinical Pediatrics","first-page":"1447","article-title":"Acne and related disorders","author":"Gollnick","year":"2012"},{"issue":"9","key":"10.1016\/j.jaad.2017.09.078_bib2","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jdv.13675","article-title":"A consensus-based practical and daily guide for the treatment of acne patients","volume":"30","author":"Gollnick","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/jdv.13776","article-title":"European evidence-based (S3) guideline for the treatment of acne - update 2016-short version","volume":"30","author":"Nast","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib4","first-page":"26","article-title":"A review of the safety and efficacy of benzoyl peroxide (5.3%) emollient foam in the management of truncal acne vulgaris","volume":"3","author":"Bikowski","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib5","first-page":"285","article-title":"Management of truncal acne vulgaris: current perspectives on treatment","volume":"77","author":"Del Rosso","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.09.078_bib6","first-page":"551","article-title":"Prevalence and severity of facial and truncal acne in a referral cohort","volume":"7","author":"Tan","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2017.09.078_bib7","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/1346-8138.13263","article-title":"Frequency and\u00a0characteristics of acne-related post-inflammatory hyperpigmentation","volume":"43","author":"Abad-Casintahan","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib8","first-page":"97","article-title":"Prevalence and risk factors of acne scarring among patients consulting dermatologists in the Unites States","volume":"16","author":"Tan","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne: a report from a Global Alliance to Improve Outcomes in Acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","article-title":"New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group","volume":"60","author":"Thiboutot","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib11","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1111\/jdv.14206","article-title":"Propionibacterium acnes phylotypes and acne severity: an observational prospective study","volume":"31","author":"Paugam","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib12","first-page":"78","article-title":"Identifying the core content of a dermatology module for Malaysian medical undergraduate curriculum using a modified Delphi method","volume":"23","author":"Jamil","year":"2016","journal-title":"Malays J Med Sci"},{"key":"10.1016\/j.jaad.2017.09.078_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaad.2008.10.066","article-title":"Medical student core curriculum in dermatology survey","volume":"61","author":"McCleskey","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib15","first-page":"18","article-title":"Clasificacion del acne: consenso Ibero-Latinoamericano, 2014","volume":"43","author":"Kaminsky","year":"2015","journal-title":"Medicina Cutanea"},{"key":"10.1016\/j.jaad.2017.09.078_bib16","first-page":"195","article-title":"An experimental application of the Delphi method to the use of experts","volume":"9","author":"Dalkey","year":"1963","journal-title":"Manag Sci"},{"key":"10.1016\/j.jaad.2017.09.078_bib17","year":"2005"},{"key":"10.1016\/j.jaad.2017.09.078_bib18","first-page":"79","article-title":"Evolution of acne assessments and impact on acne medications: an evolving, imperfect paradigm","volume":"15","author":"Stein Gold","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib19","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/bjd.13191","article-title":"A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene\/benzoyl peroxide plus doxycycline vs. oral isotretinoin","volume":"171","author":"Tan","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40257-016-0178-4","article-title":"Moderate and severe inflammatory acne vulgaris effectively treated with single-agent therapy by a new fixed-dose combination adapalene 0.3 %\/benzoyl peroxide 2.5% gel: a randomized, double-blind, parallel-group, controlled study","volume":"17","author":"Stein Gold","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2016.08.053","article-title":"Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: a phase IIa, multicenter, randomized, vehicle-controlled study","volume":"76","author":"Bissonnette","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib22","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jaad.2015.09.065","article-title":"Topical minocycline foam for moderate-to-severe acne vulgaris: phase 2 randomized double-blind, vehicle-controlled study results","volume":"74","author":"Shemer","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/13543784.2017.1337745","article-title":"Anti-acne drugs in phase 1 and 2 clinical trials","volume":"26","author":"Zouboulis","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaad.2017.09.078_bib25","first-page":"22","article-title":"Sub-group analyses from a trial of a fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% gel for the treatment of moderate-to-severe acne vulgaris","volume":"8","author":"Gold","year":"2015","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib26","first-page":"1083","article-title":"An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris","volume":"13","author":"Pariser","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib27","first-page":"94","article-title":"Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg","volume":"85","author":"Gold","year":"2010","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.09.078_bib28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2133.2011.10374.x","article-title":"Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study","volume":"165","author":"Dreno","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib29","first-page":"619","article-title":"A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic\/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris","volume":"12","author":"Zaenglein","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1365-2133.2001.04276.x","article-title":"Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents","volume":"145","author":"Thielitz","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/jdv.12823","article-title":"A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne","volume":"29","author":"Thielitz","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s13555-017-0185-2","article-title":"Why topical retinoids are mainstay of therapy for acne","volume":"7","author":"Leyden","year":"2017","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2017.09.078_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2133.1993.tb03163.x","article-title":"An in\u00a0vivo experimental model for effects of topical retinoic acid in human skin","volume":"129","author":"Griffiths","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib34","first-page":"773","article-title":"An ultrastructural study of the effects of topical tretinoin on microcomedones","volume":"14","author":"Lavker","year":"1992","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2017.09.078_bib35","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1600-0625.2011.01339.x","article-title":"Ex\u00a0vivo demonstration of a synergistic effect of adapalene and benzoyl peroxide on inflammatory acne lesions","volume":"20","author":"Zuliani","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1600-0625.2007.00552.x","article-title":"In\u00a0vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions","volume":"16","author":"Tenaud","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaad.2004.10.879","article-title":"Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial","volume":"54","author":"Thiboutot","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib38","first-page":"145","article-title":"The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: a randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle","volume":"76","author":"Pariser","year":"2005","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.09.078_bib39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1473-2165.2010.00490.x","article-title":"Medication adherence among acne patients: a review","volume":"9","author":"Lott","year":"2010","journal-title":"J\u00a0Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib40","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2147\/PPA.S117437","article-title":"Interventions to increase adherence to acne treatment","volume":"10","author":"Moradi Tuchayi","year":"2016","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jaad.2017.09.078_bib41","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jaad.2016.01.011","article-title":"Use of topical retinoids by dermatologists and non-dermatologists in the management of acne vulgaris","volume":"74","author":"Pena","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2017.09.078_bib42","article-title":"Cost-effectiveness analysis\u00a0of using dermatologists versus pediatricians to treat mild to moderate acne","volume":"23","author":"Davis","year":"2017","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2017.09.078_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archderm.138.4.481","article-title":"Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel","volume":"138","author":"Bershad","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.det.2015.11.001","article-title":"The relationship of proper skin cleansing to pathophysiology, clinical benefits, and the concomitant use of prescription topical therapies in patients with acne vulgaris","volume":"34","author":"Levin","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2017.09.078_bib45","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1684\/ejd.2014.2309","article-title":"Antibiotic stewardship in dermatology: limiting antibiotic use in acne","volume":"24","author":"Dreno","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib46","first-page":"1331","article-title":"A call to limit antibiotic use in acne. Journal of drugs in dermatology :","volume":"12","author":"Thiboutot","year":"2013","journal-title":"JDD"},{"key":"10.1016\/j.jaad.2017.09.078_bib47","first-page":"1319","article-title":"Verantwortlicher Umgang mit Antibiotika: Notwendigkeit der Antibiotikareduktion in der Aknetherapie","volume":"14","author":"Gollnick","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2017.09.078_bib48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4161\/viru.23706","article-title":"How to educate prescribers in antimicrobial stewardship practices","volume":"4","author":"Pulcini","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.jaad.2017.09.078_bib49","series-title":"The Evolving Threat of Antimicrobial Resistance - Options for Action","year":"2012"},{"key":"10.1016\/j.jaad.2017.09.078_bib50","series-title":"Antimicrobial (drug) Resistance","year":"2013"},{"key":"10.1016\/j.jaad.2017.09.078_bib51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2133.2003.05067.x","article-title":"Antibiotic-resistant acne: lessons from Europe","volume":"148","author":"Ross","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib52","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaad.2016.06.057","article-title":"Duration of oral tetracycline-class antibiotic therapy and use of topical retinoids for the treatment of acne among general practitioners (GP): a retrospective cohort study","volume":"75","author":"Barbieri","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib53","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2015.11.025","article-title":"Staphylococcus aureus carriage rates and antibiotic resistance patterns in patients with acne vulgaris","volume":"74","author":"Delost","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib54","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1540-9740.2003.03014.x","article-title":"Subantimicrobial dose doxycycline for acne and rosacea","volume":"2","author":"Bikowski","year":"2003","journal-title":"Skinmed"},{"key":"10.1016\/j.jaad.2017.09.078_bib55","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.2005.06614.x","article-title":"Treatment of acne with topical antibiotics: lessons from clinical studies","volume":"153","author":"Simonart","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib56","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1517\/14656566.2011.553192","article-title":"Treating acne with antibiotic-resistant bacterial colonization","volume":"12","author":"Tzellos","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaad.2017.09.078_bib57","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0190-9622(80)80074-0","article-title":"The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial","volume":"3","author":"Farrell","year":"1980","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib58","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(80)92273-4","article-title":"13-cis retinoic acid and acne","volume":"2","author":"Jones","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2017.09.078_bib59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000246134","article-title":"Roaccutane treatment guidelines: results of an international survey","volume":"194","author":"Cunliffe","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.09.078_bib60","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0190-9622(08)80252-6","article-title":"Guidelines for optimal use of isotretinoin in acne","volume":"27","author":"Layton","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1203475415595776","article-title":"Evaluation of evidence for acne remission with oral isotretinoin cumulative dosing of 120-150 mg\/kg","volume":"20","author":"Tan","year":"2016","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2017.09.078_bib62","first-page":"565","article-title":"An expert view on\u00a0the\u00a0treatment of acne with systemic antibiotics and\/or oral isotretinoin in the light of the new European recommendations","volume":"16","author":"Dreno","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib63","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/ijd.12942","article-title":"Making sense of the effects of the cumulative dose of isotretinoin in acne vulgaris","volume":"55","author":"Rademaker","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib64","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000018130","article-title":"Predictive factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients","volume":"198","author":"Lehucher-Ceyrac","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.09.078_bib65","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000090655","article-title":"Heredity: a prognostic factor for acne","volume":"212","author":"Ballanger","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.09.078_bib66","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jaad.2005.11.1061","article-title":"Low-dose isotretinoin in the treatment of acne vulgaris","volume":"54","author":"Amichai","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib67","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000182270","article-title":"Acute acne flare following isotretinoin administration: potential protective role of low starting dose","volume":"218","author":"Borghi","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.09.078_bib68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000350820","article-title":"Maintenance therapy for acne vulgaris: efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature","volume":"227","author":"Bettoli","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.09.078_bib69","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/archderm.142.5.605","article-title":"Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study","volume":"142","author":"Leyden","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib70","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archderm.142.5.597","article-title":"Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study","volume":"142","author":"Thiboutot","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib71","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1468-3083.2007.02190.x","article-title":"Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%","volume":"21","author":"Thielitz","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib72","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1365-2133.2011.10344.x","article-title":"A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial","volume":"164","author":"Poulin","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib73","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/09546630410021702","article-title":"A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%","volume":"15","author":"Zhang","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2017.09.078_bib74","first-page":"45","article-title":"Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline","volume":"17","author":"Alirezai","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib75","first-page":"586","article-title":"Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study","volume":"10","author":"Kircik","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib76","article-title":"Light therapies for acne: abridged Cochrane systematic review including GRADE assessments","author":"Barbaric","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib77","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/jdv.12757","article-title":"Large-scale international study enhances understanding of an emerging acne population: adult females","volume":"29","author":"Dreno","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib78","first-page":"23","article-title":"Adapalene-benzoyl peroxide gel is efficacious and safe in\u00a0adult female acne, with a profile comparable to that seen in teen-aged females","volume":"9","author":"Gold","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib79","first-page":"32","article-title":"Adapalene 0.3% for the treatment of acne in women","volume":"6","author":"Berson","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2017.09.078_bib80","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/jdv.14379","article-title":"A skincare combined with fixed adapalene and benzoyl peroxide combination provides a significant adjunctive efficacy and local tolerance benefit in adult women with mild acne","volume":"31","author":"Bouloc","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib81","first-page":"37","article-title":"Emerging issues in adult female acne","volume":"10","author":"Zeichner","year":"2017","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib82","first-page":"1416","article-title":"Evaluating and treating the adult female patient\u00a0with acne","volume":"12","author":"Zeichner","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib83","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2230.1994.tb01200.x","article-title":"A clinical evaluation of acne scarring and its incidence","volume":"19","author":"Layton","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2017.09.078_bib84","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000246015","article-title":"Scarred for life?","volume":"195","author":"Layton","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.09.078_bib85","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2310\/7750.2010.09037","article-title":"Development and validation of a Scale for Acne Scar Severity (SCAR-S) of the face and trunk","volume":"14","author":"Tan","year":"2010","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.jaad.2017.09.078_bib86","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2133.2004.05749.x","article-title":"Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar","volume":"150","author":"Holland","year":"2004","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2017.09.078_bib87","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/jdv.14325","article-title":"Development of an atrophic acne scar risk assessment tool","volume":"31","author":"Tan","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib88","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/jdv.14026","article-title":"Adapalene 0.1%\/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial","volume":"31","author":"Dreno","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib89","series-title":"Natural history of acne lesions and atrophic acne scars within a 6 month study period","author":"Bourdes","year":"2015"},{"key":"10.1016\/j.jaad.2017.09.078_bib90","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1067\/mjd.2003.274","article-title":"Ethnic skin disorders overview","volume":"48","author":"Halder","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib91","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaad.2007.01.031","article-title":"A survey of skin disease and skin-related issues in Arab Americans","volume":"56","author":"El-Essawi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib92","doi-asserted-by":"crossref","first-page":"400","DOI":"10.5812\/ircmj.5358","article-title":"The association between\u00a0melasma and postinflammatory hyperpigmentation in acne patients","volume":"15","author":"Adalatkhah","year":"2013","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.jaad.2017.09.078_bib93","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2340\/00015555-1225","article-title":"Hydroquinone therapy for post-inflammatory hyperpigmentation secondary to acne: not just prescribable by dermatologists","volume":"92","author":"Chandra","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib94","first-page":"19","article-title":"Considerations for treating acne in ethnic skin","volume":"76","author":"Callender","year":"2005","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.09.078_bib95","series-title":"The Pigmentary System Physiology and Pathophysiology","article-title":"Melanosomal translocation and transfer","author":"Jimbow","year":"1998"},{"key":"10.1016\/j.jaad.2017.09.078_bib96","first-page":"42","article-title":"Refractory postinflammatory hyperpigmentation treated fractional CO2 laser","volume":"7","author":"Oram","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib97","first-page":"33","article-title":"Concomitant therapy for acne in patients with skin of color: a case-based approach","volume":"21","author":"Alexis","year":"2009","journal-title":"Dermatol Nurs"},{"key":"10.1016\/j.jaad.2017.09.078_bib98","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.3390\/ijms10094066","article-title":"Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration","volume":"10","author":"Ebanks","year":"2009","journal-title":"Int J Mol Sci"},{"issue":"Suppl 7","key":"10.1016\/j.jaad.2017.09.078_bib99","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jdv.14491","article-title":"Management of acne in the Middle East","volume":"31","author":"Gollnick","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib100","first-page":"20","article-title":"Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color","volume":"3","author":"Davis","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib101","first-page":"45","article-title":"Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study","volume":"77","author":"Grimes","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.09.078_bib102","first-page":"s123","article-title":"Natural ingredients for darker skin types: growing options for hyperpigmentation","volume":"12","author":"Alexis","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib103","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jocd.12301","article-title":"Evaluation of salicylic acid peeling in comparison with topical\u00a0tretinoin in the treatment of postinflammatory hyperpigmentation","volume":"16","author":"Mohamed Ali","year":"2017","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib104","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bjps.2008.03.020","article-title":"The hidden cost of skin scars: quality of life after skin scarring","volume":"61","author":"Brown","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jaad.2017.09.078_bib105","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0151-9638(06)71053-5","article-title":"Acne scars: epidemiology, physiopathology, clinical features and treatment","volume":"133","author":"Chivot","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib106","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.det.2015.11.009","article-title":"Evaluation of acne scars: how to assess them and what to tell the patient","volume":"34","author":"Fife","year":"2016","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.jaad.2017.09.078_bib107","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1468-3083.2012.04461.x","article-title":"Classification of acne scars is difficult even for acne experts","volume":"27","author":"Finlay","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib108","first-page":"693","article-title":"New atrophic acne scar classification: reliability of assessments based on size, shape, and number","volume":"15","author":"Kang","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib109","article-title":"New evidence-based facial acne scar evaluation tool (FASET) to assess atrophic scars","author":"Dreno","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jaad.2008.05.029","article-title":"Acne scarring: a review and current treatment modalities","volume":"59","author":"Rivera","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib111","first-page":"CD011946","article-title":"Interventions for acne scars","volume":"4","author":"Abdel Hay","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2017.09.078_bib112","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1067\/mjd.2002.120788","article-title":"Keloidal scars: a review with a critical look at therapeutic options","volume":"46","author":"Shaffer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib113","first-page":"152","article-title":"A double-blinded, randomized, vehicle-controlled, multicenter, parallel-group study to assess the safety and efficacy of tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adults","volume":"80","author":"Berger","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.09.078_bib114","first-page":"31","article-title":"Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris","volume":"8","author":"Del Rosso","year":"2015","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib115","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1468-3083.2009.03099.x","article-title":"Interest of the association retinaldehyde\/glycolic acid in adult acne","volume":"23","author":"Dreno","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.078_bib116","first-page":"177","article-title":"Topical therapy for acne in women: is there a role for clindamycin phosphate-benzoyl peroxide gel?","volume":"94","author":"Del Rosso","year":"2014","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.09.078_bib117","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2017.09.078_bib118","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jaad.2014.03.051","article-title":"Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris","volume":"71","author":"Koo","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.078_bib119","first-page":"83","article-title":"Combined oral contraceptives for the treatment of acne: a practical guide","volume":"90","author":"Arrington","year":"2012","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.09.078_bib120","first-page":"62","article-title":"Selecting and monitoring hormonal contraceptives: an overview of available products","volume":"6","author":"Rice","year":"2006","journal-title":"US Pharm"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217326038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217326038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:44:19Z","timestamp":1759272259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217326038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0190962217326038"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.09.078","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.09.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}